Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes

Mise à jour : Il y a 4 ans
Référence : NCT00118287

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This phase I/II trial studies how well giving azacitidine together with etanercept works in treating patients with myelodysplastic syndromes (MDS). Drugs used in chemotherapy, such as azacitidine, works in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Chemoprotective drugs, such as etanercept, may protect normal cells from the side effects of chemotherapy


Critère d'inclusion

  • de Novo Myelodysplastic Syndromes,Previously Treated Myelodysplastic Syndromes,Secondary Myelodysplastic Syndromes

Liens